Muctarr Sesay, Ph.D.
In recent years, complex and high-value biologics products, such as monoclonal and multispecific antibodies, exosomes, and bioconjugates, have made significant strides, and biopharmaceutical ...
The Pharma’s Almanac editorial team is very excited to present our Q3 digital issue, which features new content from our team and our colleagues at Nice Insight on a range of trending topics and from some truly remarkable subject matter experts from across the pharma/biopharma ecosystem, including drug discovery and development companies, life science industrials, technology providers, consultants, and contract development and manufacturing organizations. The featured articles address topics that span the biopharmaceutical value chain, threaded throughout with reminders to always consider the patient, throughout discovery, formulation, manufacturing, and beyond.
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Check out the top 100 articles and trending topics our subscribers are reading right now.
Discover which PA contributors have had the most readers.
Find out which companies have been viewed the most in each industry segment.
View more about the industry-leading companies who contributed to Pharma's Almanac.
View Full Company Directory